Ross\Johnson & Associates’s Clorox CLX Stock Holding History

Ross\Johnson & Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13	Closed	-$1.91K	–	231
2025 Q1	$1.91K	Buy	+13	New	+$1.99K	0.03%	172

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ross\Johnson & Associates's CLX Position: Q2 2025 in Review

Ross\Johnson & Associates sold out of Clorox (CLX) in Q2 2025, closing a stake of 13 shares — an estimated $1.91K sold.

Ross\Johnson & Associates first reported a position in CLX in Q1 2025 and held it in 1 quarter. The position peaked at $1.91K in Q1 2025. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

Ross\Johnson & Associates reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
Ross\Johnson & Associates sold 13 Clorox shares in Q2 2025, an estimated $1.91K.
Ross\Johnson & Associates first reported a position in Clorox in Q1 2025 and held it in 1 quarter.
Ross\Johnson & Associates's Clorox position peaked at $1.91K in Q1 2025.
1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Ross\Johnson & Associates's 13F filing for Q2 2025, filed 15 Aug 2025.